U.S. FDA advisers vote in favor of Pfizer/BioNTech COVID-19 vaccine in young kids

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/7/2026

1. SPCX
2. CRNX
3. USO
4. VRTX
5. SPY
6. NVDA
7. LMT
8. WMT
9. CMPS
10. RIVN

Go back to U.S. FDA advisers vote in favor of Pfizer/BioNTech COVID-19 vaccine in young kids

US Govt Purchases Additional 50M Doses of Pfizer (PFE) and BioNTech (BNTX) COVID-19 Vaccine

October 28, 2021 6:45 AM EDT

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. government has purchased 50 million more doses of the companies COVID-19 vaccine. The U.S. will receive these additional doses to continue to support preparedness for pediatric vaccinations, including securing vaccines for children under 5 years of age, should they receive regulatory authorization. The companies expect to deliver all these doses by April 30, 2022.

With this order, the U.S. government has... More

FDA AdCom Votes in Favor of Emergency Use Authorization for Pfizer (PFE) and BioNTech's (BNTX) Covid-19 Vaccine in Children 5 to <12 Years

October 27, 2021 5:51 AM EDT

Pfizer Inc. (NYSE: PFE) and... More